Raltegravir in patients with tuberculosis. Pozniak, A. & Meintjes, G. A The Lancet Infectious Diseases, 21(6):748–749, Elsevier, mar, 2021.
Raltegravir in patients with tuberculosis [link]Paper  doi  bibtex   
@article{Pozniak2021,
author = {Pozniak, Anton and Meintjes, Graeme A},
doi = {10.1016/S1473-3099(20)30937-3},
file = {:C$\backslash$:/Users/01462563/AppData/Local/Mendeley Ltd./Mendeley Desktop/Downloaded/Pozniak, Meintjes - 2021 - Raltegravir in patients with tuberculosis.pdf:pdf},
issn = {14733099},
journal = {The Lancet Infectious Diseases},
keywords = {commentary,fund{\_}not{\_}ack},
mendeley-tags = {commentary,fund{\_}not{\_}ack},
month = {mar},
number = {6},
pages = {748--749},
pmid = {33667407},
publisher = {Elsevier},
title = {{Raltegravir in patients with tuberculosis}},
url = {https://linkinghub.elsevier.com/retrieve/pii/S1473309920309373},
volume = {21},
year = {2021}
}

Downloads: 0